https://www.socictopen.socict.org/index.php/items/show/8151
title: The widely promoted antimalarial drug hydroxychloroquine confers no mortality benefit in hospitalized patients with COVID-19: comment on the 'Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19'.
creator: Giovanna Liuzzo, Carlo Patrono
source: European heart journal
date: 2020